Supernus Pharmaceuticals

SUPN

NASDAQHealth Care

Income Statement

Total Revenue$661.82M

Gross Profit$583.91M

Operating Income$75.56M

EBITDA$178.28M

EBIT$97.87M

Pre-tax Income$-49.15M

Net Income$73.87M

Cash Equivalent$54.12M

Total Debt$29.9M

Book Value$982.38M

Book Value Per Share17.86

Return on Equity (ROE)+7.13%

Return on Assets (ROA)+5.40%

Return on Invested Capital (ROI)+7.13%

Net Profit Margin+11.16%

Current Ratio2.35

Quick Ratio2.04

Long-Term Debt / Equity0.00